Edition:
United Kingdom

Innovate Biopharmaceuticals Inc (INNT.OQ)

INNT.OQ on NASDAQ Stock Exchange Capital Market

2.29USD
18 Jan 2019
Change (% chg)

$0.07 (+3.15%)
Prev Close
$2.22
Open
$2.23
Day's High
$2.32
Day's Low
$2.13
Volume
71,539
Avg. Vol
106,932
52-wk High
$50.50
52-wk Low
$2.12

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.030
Jun '18 0.00 -0.164
Mar '18 0.00 -0.760
FY 2017 Dec '17 0.61 -2.953
Sep '17 0.14 -1.611
Jun '17 0.19 -1.939
Mar '17 0.95 -2.804
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) 1.94 49.51 6.28
Price to Book (MRQ) -- 10.16 5.27
Price to Tangible Book (MRQ) -- 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 1.38 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -88.89 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -61.60 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -26.12 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 4.49 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.15 2.18 2.26
Current Ratio (MRQ) 0.31 3.43 3.08
LT Debt to Equity (MRQ) -- 18.73 11.38
Total Debt to Equity (MRQ) -- 31.43 16.13
Interest Coverage (TTM) -3.93 -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 5.80 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -248.84 -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -232.32 -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.67 8.31
Pre-Tax Margin (TTM) -233.62 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -233.69 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,695 844,239,566
Net Income/Employee (TTM) -- 652,572 100,064,145
Receivable Turnover (TTM) 4.77 6.25 5.72
Inventory Turnover (TTM) 3.44 1.89 3.48
Asset Turnover (TTM) 0.63 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -147.16 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -- 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -- 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -50.82 5.68 --
EPS (TTM) % -3.76 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Innovate Biopharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -26.69 -29.22 4 99
13 Week -47.18 -49.75 4 95
26 Week -46.26 -50.35 12 98
52 Week -61.13 -67.06 13 72
YTD -64.69 -68.99 6 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.35%
# of Holders: 68
Total Shares Held: 2,959,725
3 Mo. Net Change: -4,301
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 4
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.